Immunome
Valuation
$25.5M
Funding
$0
Founded
2006
Immunome revenue, team size, customer count, churn, and more in 2026.
Immunome is a clinical-stage biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, focusing on improving outcomes for cancer patients.
Last updated
Immunome Revenue
We do not have information about Immunome's revenue yet.
Immunome Valuation, Funding Rounds
Immunome's most recent disclosed valuation is $25.5M.
Immunome is a bootstrapped SaaS company, self-funded since its founding in 2006, with no outside investment to date.
| Year | Round | Amount | Valuation | % Sold |
|---|
Immunome Employees & Team Size
We do not have information about Immunome's team yet.
Customers
We do not have customer count information for Immunome yet.
Frequently Asked Questions about Immunome
What is Immunome's revenue?
GetLatka has not confirmed a public revenue figure for Immunome.
How much funding does Immunome have?
Immunome raised $0.
How many employees does Immunome have?
Immunome has 0 employees.
Where is Immunome headquarters?
Immunome is headquartered in Bothell, Washington, United States.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .